Enabling Global Participation in a Rare Disease Hybrid Study for Cerebral Adrenoleukodystrophy (CALD)
Posted | November 14, 2025A global biopharmaceutical sponsor partnered with mdgroup to support a hybrid rare disease clinical trial, bringing together participants from around the world to evaluate a potential treatment for CALD. To…










